Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 48, 2011, Pages 19353-19358

  Pitzer, Virginia E ^a,c   Patel, Manish M ^d   Lopman, Ben A ^d   Viboud, Cécile ^c   Parashar, Umesh D ^d   Grenfell, Bryan T ^a,b,c  

^a PRINCETON UNIVERSITY   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Mathematical modeling; Strain replacement; Transmission dynamics

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; DEVELOPED COUNTRY; GENOTYPE; HETEROTYPIC IMMUNITY; HOMOTYPIC IMMUNITY; IMMUNITY; MATHEMATICAL MODEL; NONHUMAN; OSCILLATION; PREDICTION; PRIORITY JOURNAL; ROTAVIRUS; ROTAVIRUS INFECTION; VACCINATION; VIRUS STRAIN; VIRUS TRANSMISSION;

DEVELOPED COUNTRIES; GENOTYPE; HUMANS; MODELS, IMMUNOLOGICAL; POPULATION DYNAMICS; ROTAVIRUS; ROTAVIRUS INFECTIONS; SELECTION, GENETIC; SPECIES SPECIFICITY; VACCINATION; VIRAL VACCINES;

EID: 82755162605     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1110507108     Document Type: Article

References (57)

1. Grenfell BT, et al. (2004) Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303:327-332. (Pubitemid 38095764)
2. Andreasen V, Lin J, Levin SA (1997) The dynamics of cocirculating influenza strains conferring partial cross-immunity. J Math Biol 35:825-842.
3. Castillo-Chavez C, Hethcote HW, Andreasen V, Levin SA, Liu WM (1989) Epidemiological models with age structure, proportionate mixing, and cross-immunity. J Math Biol 27:233-258.
4. Lin J, Andreasen V, Levin SA (1999) Dynamics of influenza A drift: The linear three-strain model. Math Biosci 162:33-51.
5. Adams B, et al. (2006) Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci USA 103:14234-14239. (Pubitemid 44453009)
6. Cummings DA, Schwartz IB, Billings L, Shaw LB, Burke DS (2005) Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc Natl Acad Sci USA 102:15259-15264. (Pubitemid 41513369)
7. Ferguson N, Anderson R, Gupta S (1999) The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc Natl Acad Sci USA 96:790-794. (Pubitemid 29061287)
8. Nagao Y, Koelle K (2008) Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever. Proc Natl Acad Sci USA 105:2238-2243.
9. Recker M, et al. (2009) Immunological serotype interactions and their effect on the epidemiological pattern of dengue. Proc Biol Sci 276:2541-2548.
10. Wearing HJ, Rohani P (2006) Ecological and immunological determinants of dengue epidemics. Proc Natl Acad Sci USA 103:11802-11807. (Pubitemid 44182531)
11. Ferguson NM, Galvani AP, Bush RM (2003) Ecological and immunological determinants of influenza evolution. Nature 422:428-433. (Pubitemid 36411395)
12. Gog JR, Grenfell BT (2002) Dynamics and selection of many-strain pathogens. Proc Natl Acad Sci USA 99:17209-17214. (Pubitemid 36034123)
13. Gökaydin D, Oliveira-Martins JB, Gordo I, Gomes MG (2007) The reinfection threshold regulates pathogen diversity: The case of influenza. J R Soc Interface 4:137-142.
14. Koelle K, Cobey S, Grenfell B, Pascual M (2006) Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314:1898-1903. (Pubitemid 46026107)
15. Gupta S, Ferguson N, Anderson R (1998) Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. Science 280:912-915. (Pubitemid 28215603)
16. White LJ, Waris M, Cane PA, Nokes DJ, Medley GF (2005) The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: Seasonality and cross-protection. Epidemiol Infect 133:279-289. (Pubitemid 40439308)
17. Gupta S, Swinton J, Anderson RM (1994) Theoretical studies of the effects of heterogeneity in the parasite population on the transmission dynamics of malaria. Proc Biol Sci 256:231-238.
18. Koelle K, Pascual M, Yunus M (2006) Serotype cycles in cholera dynamics. Proc Biol Sci 273:2879-2886. (Pubitemid 44764373)
19. Martcheva M, Bolker BM, Holt RD (2008) Vaccine-induced pathogen strain replacement: What are the mechanisms? J R Soc Interface 5:3-13. (Pubitemid 350159191)
20. Matthijnssens J, et al. (2009) Rotavirus disease and vaccination: Impact on genotype diversity. Future Microbiol 4:1303-1316.
21. Estes MK, Kapikian AZ, eds (2007) Rotaviruses (Lippincott Williams & Wilkins/Wolters Kluwer, Philadelphia), 5th Ed, Vol 2, pp 1917-1974.
22. Glass RI, et al. (2006) Rotavirus vaccines: Current prospects and future challenges. Lancet 368:323-332. (Pubitemid 44067224)
23. Pitzer VE, et al. (2009) Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science 325:290-294.
24. Atchison C, Lopman B, Edmunds WJ (2010) Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales. Vaccine 28:3118-3126.
25. de Blasio BF, Kasymbekova K, Flem E (2010) Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan. Vaccine 28:7923-7932.
26. Shim E, Galvani AP (2009) Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination. Vaccine 27:4025-4030.
27. Van Effelterre T, Soriano-Gabarró M, Debrus S, Claire Newbern E, Gray J (2010) A mathematical model of the indirect effects of rotavirus vaccination. Epidemiol Infect 138:884-897.
28. Santos N, Hoshino Y (2005) Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15:29-56. (Pubitemid 40070041)
29. Clark HF, et al. (2004) Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season. J Clin Microbiol 42:1434-1438. (Pubitemid 38500777)
30. Gladstone BP, et al. (2011) Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med 365:337-346.
31. Moulton LH, Staat MA, Santosham M, Ward RL (1998) The protective effectiveness of natural rotavirus infection in an American Indian population. J Infect Dis 178:1562-1566. (Pubitemid 28558123)
32. O'Ryan ML, Matson DO, Estes MK, Bartlett AV, Pickering LK (1990) Molecular epidemiology of rotavirus in children attending day care centers in Houston. J Infect Dis 162:810-816. (Pubitemid 20336516)
33. Reves RR, et al. (1989) An observational study of naturally acquired immunity to rotaviral diarrhea in a cohort of 363 Egyptian children. Calculation of risk for second episodes using age-specific person-years of observation. Am J Epidemiol 130:981-988. (Pubitemid 19285336)
34. Velázquez FR, et al. (1996) Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 335:1022-1028. (Pubitemid 26338732)
35. Green KY, Taniguchi K, Mackow ER, Kapikian AZ (1990) Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: Implications for vaccine development. J Infect Dis 161:667-679. (Pubitemid 20120223)
36. Rojas AM, Boher Y, Guntiñas MJ, Pérez-Schael I (1995) Homotypic immune response to primary infection with rotavirus serotype G1. J Med Virol 47:404-409. (Pubitemid 26018996)
37. Ward R (2009) Mechanisms of protection against rotavirus infection and disease. Pediatr Infect Dis J 28(3, Suppl)S57-S59.
38. Carvalho-Costa FA, et al. (2009) Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil. Emerg Infect Dis 15:95-97.
39. Carvalho-Costa FA, et al. (2011) Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009. Pediatr Infect Dis J 30(1, Suppl)S35-S41.
40. Gurgel RG, et al. (2009) Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program. Gastroenterology 137:1970-1975.
41. Kirkwood CD, Boniface K, Barnes GL, Bishop RF (2011) Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia. Pediatr Infect Dis J 30(1, Suppl)S48-S53.
42. Kirkwood CD, Boniface K, Bishop RF, Barnes GL (2010) Australian Rotavirus Surveillance Program: Annual report, 2009/2010. Commun Dis Intell 34:427-434.
43. Arista S, et al. (2006) Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population. J Virol 80:10724-10733. (Pubitemid 44628918)
44. Bányai K, et al. (2009) Trends in the epidemiology of human G1P[8] rotaviruses: A Hungarian study. J Infect Dis 200(Suppl 1):S222-S227.
45. Cilla G, Montes M, Gomariz M, Piñeiro L, Pérez-Trallero E (2010) Rotavirus genotypes in children in the Basque Country (northern Spain) over a 13-year period (July 1996-June 2009). Eur J Clin Microbiol Infect Dis 29:955-960.
46. Gentsch JR, et al.; collaborating laboratories of the National Rotavirus Strain Surveillance System (2009) G and P types of circulating rotavirus strains in the United States during 1996-2005: Nine years of prevaccine data. J Infect Dis 200(Suppl 1):S99-S105.
47. Hull JJ, et al.; National Rotavirus Strain Surveillance System (2011) United States rotavirus strain surveillance from 2005 to 2008: Genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 30(1, Suppl):S42-S47.
48. Kirkwood CD, et al. (2009) Rotavirus strain surveillance - an Australian perspective of strains causing disease in hospitalised children from 1997 to 2007. Vaccine 27(Suppl 5):F102-F107.
49. Nakagomi T, Chang BR, Nakagomi O (2009) Rotavirus hospitalization and molecular epidemiology in northern Japan, 1987-1996. Vaccine 27(Suppl 5):F93-F96.
50. José MV, Bishop RF (2003) Scaling properties and symmetrical patterns in the epidemiology of rotavirus infection. Philos Trans R Soc Lond B Biol Sci 358:1625-1641. (Pubitemid 37298633)
51. José MV, Bobadilla JR, Bishop RF (1996) Oscillatory fluctuations in the incidence of rotavirus infections by serotypes 1, 2, 3, and 4. J Diarrhoeal Dis Res 14:194-200. (Pubitemid 126763970)
52. Parra GI (2009) Seasonal shifts of group A rotavirus strains as a possible mechanism of persistence in the human population. J Med Virol 81:568-571.
53. Page NA, Steele AD (2004) Antigenic and genetic characterization of serotype G2 human rotavirus strains from South Africa from 1984 to 1998. J Med Virol 72:320-327. (Pubitemid 38020563)
54. McDonald SM, et al. (2009) Evolutionary dynamics of human rotaviruses: Balancing reassortment with preferred genome constellations. PLoS Pathog 5:e1000634.
55. Smith DJ, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376. (Pubitemid 38938148)
56. Fraser C, et al.; WHO Rapid Pandemic Assessment Collaboration (2009) Pandemic potential of a strain of influenza A (H1N1): Early findings. Science 324:1557-1561.
57. Thomas SJ, Endy TP (2011) Critical issues in dengue vaccine development. Curr Opin Infect Dis 24:442-450.